FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

8940901000001109: Available (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298801000001112 Available (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298901000001118 Available en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Available Is a Non-availability indicator true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Foodlink Complete powder with fibre 63g sachets chocolate (Nualtra Limited) 1 sachet (product) VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Foodlink Complete powder with fibre 63g sachets natural (Nualtra Limited) 1 sachet (product) VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Foodlink Complete powder with fibre 63g sachets strawberry (Nualtra Limited) 1 sachet (product) VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Foodlink Complete powder with fibre Starter Pack (Nualtra Limited) 5 sachet 1 x (5 x 63g sachets) (product) VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Vesicare 1mg/ml oral suspension (Astellas Pharma Ltd) 150 ml VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Tremfya 100mg/1ml solution for injection pre-filled pens (Janssen-Cilag Ltd) 1 pre-filled disposable injection VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Isotretinoin 10mg capsules (Sun Pharmaceutical Industries Europe B.V.) 30 capsule VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Regaine for Women Once a Day 5% scalp foam (McNeil Products Ltd) 120 gram 2 x 60g VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Losartan 100mg / Hydrochlorothiazide 25mg tablets (Medreich Plc) 28 tablet VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (A A H Pharmaceuticals Ltd) 28 tablet VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Buprenorphine 2mg / Naloxone 500microgram sublingual tablets sugar free (A A H Pharmaceuticals Ltd) 28 tablet VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Paracetamol 500mg effervescent tablets sugar free (A A H Pharmaceuticals Ltd) 24 tablet 6 x 4 tablets VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Ezetimibe 10mg tablets (Accord Healthcare Ltd) 28 tablet VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Chloramphenicol 1% eye ointment (Medicom Healthcare Ltd) 4 gram VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Dorzolamide 20mg/ml / Timolol 5mg/ml eye drops (Medicom Healthcare Ltd) 5 ml VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 3 x 5 x 0.25ml unit doses VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Dorzolamide 20mg/ml eye drops (Medicom Healthcare Ltd) 5 ml VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Brimonidine 2mg/ml eye drops (Medicom Healthcare Ltd) 5 ml VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Medox 50micrograms/ml / 5mg/ml eye drops (Medicom Healthcare Ltd) 2.5 ml VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Duloxetine 30mg gastro-resistant capsules (Tillomed Laboratories Ltd) 28 capsule VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Nabumetone 500mg tablets (Tillomed Laboratories Ltd) 56 tablet VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Paroxetine 20mg tablets (Tillomed Laboratories Ltd) 30 tablet VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (Tillomed Laboratories Ltd) 3 tablet VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (Tillomed Laboratories Ltd) 6 tablet VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Tranexamic acid 500mg tablets (Tillomed Laboratories Ltd) 60 tablet VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Furosemide 40mg tablets (Alliance Healthcare (Distribution) Ltd) 250 tablet VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Olanzapine 5mg orodispersible tablets (Alliance Healthcare (Distribution) Ltd) 28 tablet 4 x 7 tablets VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Olanzapine 10mg orodispersible tablets (Alliance Healthcare (Distribution) Ltd) 28 tablet 4 x 7 tablets VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Olanzapine 15mg orodispersible tablets (Alliance Healthcare (Distribution) Ltd) 28 tablet 4 x 7 tablets VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Olanzapine 20mg orodispersible tablets (Alliance Healthcare (Distribution) Ltd) 28 tablet 4 x 7 tablets VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Lidocaine 100mg/5ml (2%) solution for injection Mini-Plasco ampoules (B.Braun Medical Ltd) 100 ampoule VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Tramadol 37.5mg / Paracetamol 325mg tablets (Accord Healthcare Ltd) 60 tablet VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Anagrelide 500microgram capsules (Dr Reddy's Laboratories (UK) Ltd) 100 capsule VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Trifluoperazine 5mg/5ml oral solution sugar free (Focus Pharmaceuticals Ltd) 150 ml VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Ixyldone 60mg modified-release tablets (Morningside Healthcare Ltd) 56 tablet 4 x 14 tablets VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Pelgraz 6mg/0.6ml solution for Injection pre-filled syringes (Accord Healthcare Ltd) 1 pre-filled disposable injection VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Ixyldone 10mg modified-release tablets (Morningside Healthcare Ltd) 56 tablet 4 x 14 tablets VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Ixyldone 20mg modified-release tablets (Morningside Healthcare Ltd) 56 tablet 4 x 14 tablets VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Ixyldone 40mg modified-release tablets (Morningside Healthcare Ltd) 56 tablet 4 x 14 tablets VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Ixyldone 30mg modified-release tablets (Morningside Healthcare Ltd) 56 tablet 4 x 14 tablets VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Ixyldone 80mg modified-release tablets (Morningside Healthcare Ltd) 56 tablet 4 x 14 tablets VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Ixyldone 15mg modified-release tablets (Morningside Healthcare Ltd) 56 tablet 4 x 14 tablets VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Ixyldone 60mg modified-release tablets (Morningside Healthcare Ltd) VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Pelgraz 6mg/0.6ml solution for Injection pre-filled syringes (Accord Healthcare Ltd) VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Lidocaine 50mg/5ml (1%) solution for injection Mini-Plasco ampoules (B.Braun Medical Ltd) VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Lidocaine 400mg/20ml (2%) solution for injection Mini-Plasco ampoules (B.Braun Medical Ltd) VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Ixyldone 20mg modified-release tablets (Morningside Healthcare Ltd) VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Ixyldone 10mg modified-release tablets (Morningside Healthcare Ltd) VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Lidocaine 200mg/20ml (1%) solution for injection Mini-Plasco ampoules (B.Braun Medical Ltd) VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Trifluoperazine 5mg/5ml oral solution sugar free (Focus Pharmaceuticals Ltd) VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Ixyldone 30mg modified-release tablets (Morningside Healthcare Ltd) VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Ixyldone 15mg modified-release tablets (Morningside Healthcare Ltd) VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Ixyldone 80mg modified-release tablets (Morningside Healthcare Ltd) VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Ixyldone 40mg modified-release tablets (Morningside Healthcare Ltd) VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Lidocaine 400mg/20ml (2%) solution for injection Mini-Plasco ampoules (B.Braun Medical Ltd) 100 ampoule VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Lidocaine 50mg/5ml (1%) solution for injection Mini-Plasco ampoules (B.Braun Medical Ltd) 100 ampoule VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Lidocaine 200mg/20ml (1%) solution for injection Mini-Plasco ampoules (B.Braun Medical Ltd) 100 ampoule VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Atracurium besilate 25mg/2.5ml solution for injection ampoules 10 ampoule VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Esmolol 100mg/10ml solution for injection vials 10 vial VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Lidocaine 50mg/5ml (1%) solution for injection ampoules 100 ampoule VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Lidocaine 400mg/20ml (2%) solution for injection ampoules 100 ampoule VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Lidocaine 200mg/20ml (1%) solution for injection ampoules 100 ampoule VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Durvalumab 500mg/10ml solution for infusion vials VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Durvalumab 120mg/2.4ml solution for infusion vials VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Acetazolamide 250mg modified-release capsules VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Acetylcysteine 5% eye drops preservative free VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Aciclovir 1g/40ml solution for infusion vials VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Aciclovir 200mg/5ml oral suspension sugar free VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Aciclovir 250mg/10ml solution for infusion vials VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Aciclovir 500mg/20ml solution for infusion vials VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Barium sulfate suspension VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Beractant 200mg/8ml endotracheopulmonary suspension bottles VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Cantharidin 0.7% collodion VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Cefuroxime 1.5g/50ml infusion bags VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Cefuroxime 750mg/50ml infusion bags VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Esmolol 100mg/10ml solution for injection vials VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Flucytosine 2.5g/250ml solution for infusion bottles VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Aclidinium bromide 375micrograms/dose dry powder inhaler VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Ganirelix 250micrograms/0.5ml solution for injection pre-filled syringes VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Glyceryl trinitrate 50mg/10ml solution for infusion ampoules VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Adenosine 30mg/10ml solution for infusion vials VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Adenosine 6mg/2ml solution for injection vials VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Adrenaline (base) 1mg/10ml (1 in 10,000) dilute solution for injection ampoules VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Adrenaline (base) 1mg/1ml (1 in 1,000) solution for injection ampoules VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
High Purity Factor IX 1,500unit powder and solvent for solution for injection vials VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Adrenaline (base) 300micrograms/0.3ml (1 in 1,000) solution for injection pre-filled disposable devices VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Idursulfase 6mg/3ml solution for infusion vials VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Adrenaline (base) 5mg/5ml (1 in 1,000) solution for injection ampoules VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Levobupivacaine 125mg/100ml infusion bags VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Alfacalcidol 1micrograms/0.5ml solution for injection ampoules VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Alfacalcidol 2micrograms/1ml solution for injection ampoules VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Nitric oxide 100ppm VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Nitric oxide 800ppm VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Alfentanil 1mg/2ml solution for injection ampoules VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Alfentanil 500micrograms/1ml solution for injection ampoules VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Alfentanil 5mg/10ml solution for injection ampoules VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Alfentanil 5mg/1ml solution for injection ampoules VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Alfuzosin 10mg modified-release tablets VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Alimemazine 30mg/5ml oral solution VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Alimemazine 7.5mg/5ml oral solution VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Almond oil liquid VMP non-availability indicator True Available Inferred relationship Existential restriction modifier

Start Previous Page 3613 of 3707 Next End

This concept is not in any reference sets

Back to Start